{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:25:02Z","timestamp":1793856302246,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pdpdt.2026.105587","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:00:13Z","timestamp":1784790013000},"page":"105587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of the effects of intravitreal aflibercept and ranibizumab on optical coherence tomography findings in macular edema secondary to retinal vein occlusion"],"prefix":"10.1016","volume":"61","author":[{"given":"Ibrahim Halil","family":"Katran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-781X","authenticated-orcid":false,"given":"Leyla","family":"Hazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruken Mehmetoglu","family":"Katran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105587_bib0001","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/APO.0000000000000598","article-title":"Update on retinal vein occlusion","volume":"12","author":"Romano","year":"2023","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0002","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00417-004-1087-4","article-title":"Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion","volume":"244","author":"Noma","year":"2006","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0004","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/archopht.120.12.1644","article-title":"Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion","volume":"120","author":"Boyd","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0005","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate","volume":"103","author":"Tolentino","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10384-018-0586-5","article-title":"Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion","volume":"62","author":"Iijima","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0007","article-title":"Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study","volume":"2015","author":"Adelman","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0008","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjo.2007.127282","article-title":"Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study","volume":"92","author":"Kriechbaum","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000479049","article-title":"Anti-vascular endothelial Growth Factor therapy for macular edema following Central retinal vein occlusion: 1 initial injection versus 3 monthly injections","volume":"239","author":"Osaka","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2015.00248","article-title":"Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach","volume":"6","author":"Platania","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0012","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s10792-022-02344-z","article-title":"The impact of laboratory findings and optical coherence tomography biomarkers on response to intravitreal anti-VEGF treatment in patients with retinal vein occlusion","volume":"42","author":"Chatziralli","year":"2022","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oret.2018.07.008","article-title":"Disorganization of retinal inner layers and ellipsoid zone disruption predict visual outcomes in central retinal vein occlusion","volume":"3","author":"Chan","year":"2019","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0014","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ophtha.2012.01.042","article-title":"Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study","volume":"119","author":"Boyer","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bjophthalmol-2012-301504","article-title":"VEGF trap-eye for macular oedema secondary to central retinal vein occlusion: 6- month results of the phase III GALILEO study","volume":"97","author":"Holz","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0016","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"CRUISE Investigators et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0018","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ophtha.2013.11.022","article-title":"Time to clinically significant visual acuity gains after Ranibizumab treatment for retinal vein occlusion. BRAVO and CRUISE trials","volume":"121","author":"Thach","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.pdpdt.2026.105587_bib0019","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40123-024-00915-0","article-title":"Efficacy, safety, and treatment burden of Aflibercept 2 mg and Ranibizumab in Retinal vein occlusion: a systematic review and meta-analysis","volume":"13","author":"Wu","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0020","first-page":"63","article-title":"Intravitreal Aflibercept for macular edema secondary to branch retinal vein occlusion in Chinese patients","volume":"30","author":"Wang","year":"2015","journal-title":"Eye Sci."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.12.6.21","article-title":"High variation in inner retinal reflectivity predicts poor visual outcome in patients with Central retinal vein occlusion: SCORE2 report 21","volume":"12","author":"Mehta","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0022","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oret.2019.08.009","article-title":"Spectral-domain OCT predictors of visual outcomes after Ranibizumab treatment for macular edema resulting from retinal vein occlusion","volume":"4","author":"Yiu","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0023","first-page":"605","article-title":"Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion","volume":"10","author":"Mo","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0024","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00417-012-2067-8","article-title":"Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion","volume":"251","author":"Kang","year":"2013","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0025","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00417-010-1419-5","article-title":"OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion","volume":"248","author":"Hoeh","year":"2010","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0026","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/IAE.0000000000001579","article-title":"Ranibizumab for retinal vein occlusion: predictive factors and long-term outcomes in real-life data","volume":"38","author":"Chatziralli","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0027","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ajo.2013.10.007","article-title":"Presence of foveal bulge in optical coherence tomographic images in eyes with macular edema associated with branch retinal vein occlusion","volume":"157","author":"Hasegawa","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0028","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2017.08.005","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion","volume":"182","author":"Mimouni","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105587_bib0029","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/IAE.0b013e31821801f5","article-title":"Hemicentral retinal vein occlusion: natural history of visual outcome","volume":"32","author":"Hayreh","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2026.105587_bib0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.18502\/jovr.v19i3.13531","article-title":"Predictive factors for functional and anatomical outcomes after anti-VEGF treatment for macular edema in patients with branch retinal vein occlusion","volume":"19","author":"Cunha Ferreira","year":"2024","journal-title":"J. Ophthalmic. Vis. Res."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026002541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026002541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:38:40Z","timestamp":1793853520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026002541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S1572100026002541"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105587","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effects of intravitreal aflibercept and ranibizumab on optical coherence tomography findings in macular edema secondary to retinal vein occlusion","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105587"}}